Labetalol RS-SR Diastereoisomer - Request Quote
Labetalol RS-SR Diastereoisomer
| SZ CAT No: | SZ-L007009 |
| CAS No | NA |
| Mol.F. | C19H24N2O3 : HCl |
| Mol.Wt. | 328.4 : 36.5 |
| Inv. Status | In Stock |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Labetalol RS-SR Diastereoisomer is chemically 2-Hydroxy-5-((R)-1-hydroxy-2-((S)-4-phenylbutan-2-ylamino)ethyl)benzamide hydrochloride. Labetalol RS-SR Diastereoisomer is supplied with detailed characterization data compliant with regulatory guideline. Labetalol RS-SR Diastereoisomer can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Labetalol.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
buy high quality Labetalol RS-SR Diastereoisomer
Purchase Labetalol RS-SR Diastereoisomer
Labetalol RS-SR Diastereoisomer suppliers
Labetalol RS-SR Diastereoisomer manufacturers
Labetalol RS-SR Diastereoisomer price
Order Labetalol RS-SR Diastereoisomer
Enquire Labetalol RS-SR Diastereoisomer
Labetalol RS-SR Diastereoisomer cost
Labetalol RS-SR Diastereoisomer Supplier
Labetalol RS-SR Diastereoisomer Distributor
Labetalol RS-SR Diastereoisomer for Method Validation
Labetalol Reference Standard
Labetalol RS-SR Diastereoisomer for ANDA Filing
Labetalol RS-SR Diastereoisomer for Forced Degradation Studies
Labetalol RS-SR Diastereoisomer Identification Standards
Labetalol RS-SR Diastereoisomer for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


